Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Merck Serono
Darmstadt, Hesse, Germanyemdserono.com ↗
- Ownership
- Private
- Employees
- ~6000
- Development stage
- Commercial
01
Overview
Merck Serono (Merck KGaA, Darmstadt, Germany/EMD Serono) has a global commercial portfolio including approved drugs for multiple sclerosis (Rebif, Mavenclad), infertility (Gonal-f, Ovidrel), oncology (Erbitux, Bavencio), and a robust late-stage pipeline particularly in oncology and immunology. Recent strategic partnerships have added next-generation PARP1 inhibitors and antibody-drug conjugates to its pipeline. Over 20 clinical programs cover more than 15 tumor types and several autoimmune diseases[2][4][5][6][7].
- Therapeutic areas
- ImmunologyMetabolic DisordersInfectious DiseasesDermatologyOncologyNeurologyWomen's Health
- Modalities
- BiologicMonoclonal antibodyAntibody-drug conjugateSmall moleculeRecombinant protein
- Industry
- Pharma
02
Partnerships
Jiangsu Hengrui PharmaceuticalsSFJ Pharmaceuticals GroupAvillion
Beyond the preview
Go deeper on Merck Serono.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Merck Serono.